TB-500 10mg
99.2% HPLC PurityA synthetic form of Thymosin Beta-4, studied in tissue repair and cell migration research.

SKU: PW-009 • Batch: PW-260308
A 15-amino-acid pentadecapeptide derived from a gastric protective protein, studied in tissue-repair and gut research. 99.2% HPLC purity, independently verified with COA.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
A synthetic form of Thymosin Beta-4, studied in tissue repair and cell migration research.
BPC-157 and TB-500 combined 1:1 in a single vial for tissue-repair research.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protective protein found in gastric juice. Supplied as a lyophilised powder at 99.2% HPLC purity with full Certificate of Analysis documentation.
Manufactured in Australia under GMP-compliant conditions, with every batch independently tested for purity, identity, sterility and endotoxin levels before dispatch from our Australian labs.
Preclinical research has explored BPC-157 for effects on angiogenesis, collagen synthesis, nitric oxide production, and tissue repair pathways in multiple organ systems. Its stability profile (particularly its resistance to gastric acid degradation) distinguishes it from many other research peptides.
BPC-157 is a synthetic pentadecapeptide studied in preclinical research for its effects on tissue repair, angiogenesis, and gastrointestinal function. All use is strictly for in-vitro laboratory research only.
Our BPC-157 10mg is independently verified at 99.2% HPLC purity. A full COA including chromatogram, mass spec, sterility, and endotoxin data is available for each batch.
Store lyophilised BPC-157 at −20°C for long-term stability. Once reconstituted, store at 2–8°C and use within 4 weeks. Protect from light and avoid freeze-thaw cycles.
Add bacteriostatic water slowly to the vial (1–2mL recommended). Gently swirl to dissolve; do not shake or vortex. The solution should be clear with no particulates before use.
BPC-157 was added to Schedule 4 (prescription-only) of the Poisons Standard in Australia in June 2024. It is supplied here strictly for legitimate in-vitro laboratory and research purposes, is not approved for human consumption or therapeutic use, and "sold for research use" is not an exemption from that scheduling. See our research peptide legality guide for the current detail.
BPC-157 is a pentadecapeptide fragment, while TB-500 is a synthetic version of Thymosin Beta-4. They have different molecular structures and distinct research applications, though both are studied in tissue-related research contexts.
Yes. Peptide Labs ships BPC-157 nationwide across Australia via Australia Post with full tracking on every order.
Yes. Every batch ships with a downloadable COA including HPLC purity %, mass spectrometry data, sterility results, and LAL endotoxin assay confirmation.
Current batch: PW-260308. The full COA is available in our COA Library for download.
BPC-157 has a molecular weight of approximately 1419.53 Da (grams per mole), with molecular formula C₆₂H₉₈N₁₆O₂₂.
Yes,we offer a BPC-157 + TB-500 synergistic blend (10mg, 99.0% purity) for research applications requiring both compounds. See our Healing category.
BPC-157 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to BPC-157. Provided for research context — not medical advice.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review
Józwiak M, Bauer M, Kamysz W, et al. · Pharmaceuticals (Basel, Switzerland) · 2025
PMID: 40005999
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, et al. · HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
PMID: 40756949
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Gwyer D, Wragg NM, Wilson SL · Cell and tissue research · 2019
PMID: 30915550
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth S, Milavic M, Vukojevic J, et al. · Frontiers in pharmacology · 2021
PMID: 34267654
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.